In the News

1857 News Items found
An international team of researchers led by Howard Scher, MD, Co-Chair of the Center for Mechanism Based Therapy and Head of the Biomarker Development Initiative at Memorial Sloan Kettering Cancer Center (MSK), has validated a biomarker that can predict whether people with metastatic castration-resistant prostate cancer (mCRPC) may live longer if they are treated with a taxane-based chemotherapy instead of a second targeted androgen receptor–signaling inhibitor (ARSi).
MSK computational biologist Dana Pe'er
In the Lab
Sloan Kettering Institute investigators are taking important steps toward being able to identify all the cell types in tumors. With this information, they can figure out how the cells work together.
Leukemia cells
Finding
A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.
A doctor examines a mole.
Finding
It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.
Five scientists in a lab
Feature
What's it like being LGBTQ in the world of science? We asked some MSK scientists to find out.
the Bridges team at dinner
Q&A
Learn more about Memorial Sloan Kettering’s newsletter for cancer survivors, which is celebrating its tenth year of publication.
Omar Abdel-Wahab
Feature
The word “epigenetic” literally means “above the genes.” Calico cats demonstrate a type of epigenetic inheritance called X-inactivation.
Large cells filled with yellow-colored fat
Finding
Cancer Cells Eat Fat to Grow and Spread
Research conducted in zebrafish shows that melanoma cells have an affinity for fat, and that eating it makes them more aggressive.
Urology Service Chief James Eastham talks to a patient
Q&A
Learn why surgery remains a very effective treatment for most prostate cancers.
Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.
Finding
A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.